SECFilingvia Quantisnow
Faeth Therapeutics Inc. logo

FTH: Faeth registers 2.67M shares for 2026 equity and stock purchase plans

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow AI summary

Faeth Therapeutics files S-8 registering 2,671,981 common shares for its 2026 Equity Incentive Plan and 2026 ESPP.

What this filing says

Faeth Therapeutics filed a Form S-8 to register shares for employee compensation under its new 2026 Equity Incentive Plan and 2026 Employee Stock Purchase Plan. The filing covers 2,671,981 new common shares plus up to 311,164 shares that may return to the 2026 plan from the older 2021 plan. Registering shares for employee plans can lead to more shares being issued over time, which may dilute existing holders.

Key figures

Shares reserved under 2026 Equity Incentive Plan
2,671,981 shares
Shares that may move from 2021 plan
up to 311,164 shares
Par value of common stock
$0.0001 per share

Positive for shareholders

  • The registration covers equity awards that can help attract and retain staff.

Negative for shareholders

  • Up to about 2.98 million shares could be issued under these plans, which may dilute existing shareholders.

Written by Quantisnow AI from this filing. Not financial advice.

Key terms

Form S-8:
A registration statement a company files with the SEC to register shares offered to employees under compensation plans.
Employee Stock Purchase Plan:
A plan that lets employees buy company shares, often at a discount, through payroll deductions.
Dilution:
A reduction in existing shareholders' ownership percentage when new shares are issued.

FAQ

What is Faeth Therapeutics registering with this S-8?

Faeth is registering 2,671,981 common shares reserved under its 2026 Equity Incentive Plan, plus up to 311,164 shares from its 2021 plan that may become available under the 2026 plan.

Does this filing mean new shares have been issued?

Not necessarily. The filing registers shares that may be issued under the plans, and the text does not state how many have been granted or issued.

Keep researching FTH

Quantisnow market dataNASDAQ
Faeth Therapeutics Inc. logo
FTH
Faeth Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for FTH

Follow FTH and get a push notification the moment its next story breaks.

Full FTH profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FTH (Faeth Therapeutics Inc.) and more on Quantisnow.